Jpmorgan Chase & CO Zentek Ltd. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Zentek Ltd. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 20,000 shares of ZTEK stock, worth $30,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000
Previous 20,000
-0.0%
Holding current value
$30,000
Previous $18,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ZTEK
# of Institutions
23Shares Held
1.56MCall Options Held
0Put Options Held
0-
Scotia Capital Inc.901KShares$1.35 Million0.01% of portfolio
-
Federation Des Caisses Desjardins Du Quebec Levis, A8147KShares$220,7620.0% of portfolio
-
Cibc World Market Inc. Toronto, A6124KShares$186,3810.0% of portfolio
-
Royal Bank Of Canada Toronto, A688.7KShares$133,1220.0% of portfolio
-
Bank Of Montreal Toronto, A662.7KShares$93,9990.0% of portfolio
About Zentek Ltd.
- Ticker ZTEK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 99,363,104
- Market Cap $149M
- Description
- Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detec...